Ticker
VCELCompany Name
VERICEL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 204.58M | 4.97 | $ 41.13M |
3/31/2025 | $ 197.64M | 5.01 | $ 39.45M |
12/31/2024 | $ 212.78M | 4.23 | $ 50.29M |
9/30/2024 | $ 190.52M | 4.61 | $ 41.35M |
6/30/2024 | $ 197.39M | 4.5 | $ 43.86M |
3/31/2024 | $ 189.72M | 5.2 | $ 36.47M |
12/31/2023 | $ 205.63M | 4.49 | $ 45.75M |
9/30/2023 | $ 186.21M | 5.18 | $ 35.95M |
6/30/2023 | $ 182.87M | 5.14 | $ 35.61M |
3/31/2023 | $ 177.54M | 6.17 | $ 28.75M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for VERICEL CORP is calculated as follows: AssetsC [ $ 125.38M ] / LiabilitesC [ $ 21.31M ]
(=) Current Ratio [ 5.88 ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |